Opthea LtdHere is the public summary page for Opthea Ltd. Please login to see the complete information for Opthea Ltd including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Opthea Ltd stacks up relative to its peers. |
| Darwin Score | -10 |
| Ticker | OPT |
| Latest Price | 0.60 AUD as of close on 16-Jul-2025 |
| 3 Month price range | 0.60 to 0.60 AUD |
| Market Capitalisation | 738.75Mn AUD |
| Country | Australia |
| Region | Asia |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States. Its development activities are based on the intellectual property portfolio covering vascular endothelial growth factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company's lead product candidate is sozinibercept (OPT-302), a biologic drug in Phase 3 clinical trials designed to inhibit VEGF-C and VEGF-D and complement VEGF-A inhibitors for the treatment of wet age-related macular degeneration and diabetic macular edema. It serves the biotechnology and healthcare industries. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is headquartered in South Yarra, Australia. See More ... |
| Company URL | https://opthea.com |
| See Darwins Full Analysis for Opthea Ltd |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Opthea Ltd. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | -2 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | -6 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | -2 |
Alerts
There are 12 live alerts for Opthea Ltd.
- Oversold - The 15 day RSI is +11.3. (Positive)
- Oversold - The 30 day RSI is +23.9. (Positive)
- Oversold - The 5 week RSI is +10.8. (Positive)
- New Low (1m). This alert has occurred 85 times over the last last year. The average forward returns are -1.6% over 5 days, -2.1% over 10 days, -2.4% over 15 days and -2.5% over 20 days. (Negative)
- New Low (6m). This alert has occurred 63 times over the last last year. The average forward returns are 0.0% over 5 days, 0.0% over 10 days, 0.0% over 15 days and 0.0% over 20 days. (Negative)
- 5d RSI Oversold. This alert has occurred 103 times over the last last year. The average forward returns are -0.8% over 5 days, -1.1% over 10 days, -2.7% over 15 days and -3.1% over 20 days. (Negative)
- New High (1m). This alert has occurred 93 times over the last last year. The average forward returns are 3.0% over 5 days, 5.0% over 10 days, 6.4% over 15 days and 8.8% over 20 days. (Positive)
- New High (3m). This alert has occurred 25 times over the last last year. The average forward returns are 5.4% over 5 days, 9.4% over 10 days, 10.6% over 15 days and 11.2% over 20 days. (Positive)
- 30d RSI Oversold. This alert has occurred 74 times over the last last year. The average forward returns are -0.3% over 5 days, -0.3% over 10 days, -0.1% over 15 days and 0.1% over 20 days. (Negative)
- Technically Oversold - 14 day RSI less than 30. This alert has occurred 82 times over the last last year. The average forward returns are -0.9% over 5 days, -0.1% over 10 days, -0.6% over 15 days and -0.6% over 20 days. (Positive)
- 15d RSI Oversold. This alert has occurred 82 times over the last last year. The average forward returns are -0.9% over 5 days, -0.1% over 10 days, -0.6% over 15 days and -0.6% over 20 days. (Negative)
- New Low (3m). This alert has occurred 67 times over the last last year. The average forward returns are -0.1% over 5 days, -0.1% over 10 days, -0.1% over 15 days and -0.1% over 20 days. (Negative)
Peer Comparison
There are 12 peers of Opthea Ltd.
| Asset Name | Industry Group | Asset Score |
|---|---|---|
| Argenica Therapeutics Ltd (AGN) | Biotechnology | +6 |
| Arovella Therapeutics Ltd (ALA) | Biotechnology | +22 |
| CSL Ltd (CSL) | Biotechnology | +19 |
| Clinuvel Pharmaceuticals Ltd (CUV) | Biotechnology | +4 |
| Imugene Ltd (IMU) | Biotechnology | -31 |
| Mesoblast Ltd (MSB) | Biotechnology | +12 |
| PYC Therapeutics Ltd (PYC) | Biotechnology | +22 |
| Paradigm Biopharmaceuticals Ltd (PAR) | Biotechnology | +4 |
| Polynovo Ltd (PNV) | Biotechnology | +4 |
| Race Oncology Ltd (RAC) | Biotechnology | -20 |
| Telix Pharmaceuticals Ltd (TLX) | Biotechnology | +10 |
| Tissue Repair Ltd (TRP) | Biotechnology | +7 |
Share 
